Clinical Highlights From ASCO 2025
JAMA Medical News
00:00
Evaluating Meaningful Endpoints in Cancer Clinical Trials
This chapter explores a study from ASCO that critiques the use of surrogate endpoints like progression-free survival in cancer clinical trials. It highlights the disconnect between these metrics and patient priorities, while calling for regulatory changes to ensure improvements in overall survival and quality of life are prioritized.
Play episode from 16:27
Transcript
